Community Research and Development Information Service - CORDIS


New Paediatric Research Initiatives in the European Union

Funded under: FP7-HEALTH


In contrast to the situation concerning adults, most medicines used to treat the children of Europe have not been tested on children and are
not authorised for use in children. Therefore, the health and quality of life of children in the EU countries may suffer from a lack of testing
and authorisation of medicines for their use. In particular, 46% of medicines prescribed to children in hospital are either unlicensed for
their age group or, if they are, have been done so off-label.1 Of the children who receive medication in hospital this figure rises to 67%,1
and in the context of intensive care up to 90% of paediatric medicines used are not licensed.2

Download application/pdf (257941)

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top